Articles producció científica> Bioquímica i Biotecnologia

Effect of a Mediterranean Diet Supplemented With Nuts on Metabolic Syndrome Status

  • Dades identificatives

    Identificador: PC:1703
    Handle: https://hdl.handle.net/20.500.11797/PC1703
    Autors:
    Jordi Salas-SalvadoJoan Fernandez-BallartEmilio RosMiguel Angel Martinez GonzalezMontserrat FitoRamon EstruchDolores CorellaMiquel FiolEnrique Gomez GraciaFernando ArosGemma FloresJose LapetraRosa Lamuela RaventosValentina Ruiz GutierrezMònica BulloJosep BasoraMaria Isabel Covasthe PREDIMED Study Investigators
    Resum:
    BACKGROUND: Epidemiological studies suggest that the Mediterranean diet (MedDiet) may reduce the risk of developing the metabolic syndrome (MetS). We compared the 1-year effect of 2 behavioral interventions to implement the MedDiet vs advice on a low-fat diet on MetS status. METHODS: A total of 1224 participants were recruited from the PREDIMED (Prevención con Dieta Mediterránea) Study, a multicenter, 3-arm, randomized clinical trial to determine the efficacy of the MedDiet on the primary prevention of cardiovascular disease. Participants were older subjects at high risk for cardiovascular disease. Interventions were quarterly education about the MedDiet plus provision of either 1 L/wk of virgin olive oil (MedDiet + VOO) or 30 g/d of mixed nuts (MedDiet + nuts), and advice on a low-fat diet (control diet). All diets were ad libitum, and there was no increase in physical activity for any of the interventions. Lifestyle variables and MetS features as defined by the National Cholesterol Education Program Adult Treatment Panel III criteria were assessed. RESULTS: At baseline, 61.4% of participants met criteria for the MetS. One-year prevalence was reduced by 6.7%, 13.7%, and 2.0% in the MedDiet + VOO, MedDiet + nuts, and control diet groups, respectively (MedDiet + nuts vs control groups, P = .01; MedDiet + VOO vs control group, P = .18). Incident rates of the MetS were not significantly different among groups (22.9%, 17.9%, and 23.4%, respectively). After adjustment for sex, age, baseline obesity status, and weight changes, the odds ratios for reversion of MetS were 1.3 (95% confidence interval, 0.8-2.1) for the MedDiet + VOO group and 1.7 (1.1-2.6) for the MedDiet + nuts group compared with the control diet group. CONCLUSION: A traditional MedDiet enriched with nuts co

  • Altres:

    Autor segons l'article: Jordi Salas-Salvado; Joan Fernandez-Ballart; Emilio Ros; Miguel Angel Martinez Gonzalez; Montserrat Fito; Ramon Estruch; Dolores Corella; Miquel Fiol; Enrique Gomez Gracia; Fernando Aros; Gemma Flores; Jose Lapetra; Rosa Lamuela Raventos; Valentina Ruiz Gutierrez; Mònica Bullo; Josep Basora; Maria Isabel Covas; the PREDIMED Study Investigators
    Departament: Bioquímica i Biotecnologia
    Autor/s de la URV: SALAS SALVADÓ, JORGE; Joan Fernandez-Ballart; Emilio Ros; Miguel Angel Martinez Gonzalez; Montserrat Fito; Ramon Estruch; Dolores Corella; Miquel Fiol; Enrique Gomez Gracia; Fernando Aros; Gemma Flores; Jose Lapetra; Rosa Lamuela Raventos; Valentina Ruiz Gutierrez; BULLÓ BONET, MÒNICA; Josep Basora; Maria Isabel Covas; the PREDIMED Study Investigators
    Paraules clau: Metabolic Syndrome Status PREDIMED study Randomized trial
    Resum: BACKGROUND: Epidemiological studies suggest that the Mediterranean diet (MedDiet) may reduce the risk of developing the metabolic syndrome (MetS). We compared the 1-year effect of 2 behavioral interventions to implement the MedDiet vs advice on a low-fat diet on MetS status. METHODS: A total of 1224 participants were recruited from the PREDIMED (Prevención con Dieta Mediterránea) Study, a multicenter, 3-arm, randomized clinical trial to determine the efficacy of the MedDiet on the primary prevention of cardiovascular disease. Participants were older subjects at high risk for cardiovascular disease. Interventions were quarterly education about the MedDiet plus provision of either 1 L/wk of virgin olive oil (MedDiet + VOO) or 30 g/d of mixed nuts (MedDiet + nuts), and advice on a low-fat diet (control diet). All diets were ad libitum, and there was no increase in physical activity for any of the interventions. Lifestyle variables and MetS features as defined by the National Cholesterol Education Program Adult Treatment Panel III criteria were assessed. RESULTS: At baseline, 61.4% of participants met criteria for the MetS. One-year prevalence was reduced by 6.7%, 13.7%, and 2.0% in the MedDiet + VOO, MedDiet + nuts, and control diet groups, respectively (MedDiet + nuts vs control groups, P = .01; MedDiet + VOO vs control group, P = .18). Incident rates of the MetS were not significantly different among groups (22.9%, 17.9%, and 23.4%, respectively). After adjustment for sex, age, baseline obesity status, and weight changes, the odds ratios for reversion of MetS were 1.3 (95% confidence interval, 0.8-2.1) for the MedDiet + VOO group and 1.7 (1.1-2.6) for the MedDiet + nuts group compared with the control diet group. CONCLUSION: A traditional MedDiet enriched with nuts could be a useful tool in the management of the MetS.
    Grup de recerca: Alimentació, Nutrició, Creixement i Salut Mental
    Àrees temàtiques: Biochemistry and technology Bioquímica y tecnología Bioquímica i biotecnologia
    Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
    ISSN: 0003-9926
    Identificador de l'autor: N/D; N/D; N/D; N/D; N/D; N/D; N/D; N/D; N/D; N/D; N/D; N/D; N/D; N/D; N/D; N/D; N/D; N/D
    Data d'alta del registre: 2016-06-13
    Pàgina final: 2458
    Volum de revista: 168
    Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
    URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
    Entitat: Universitat Rovira i Virgili
    Any de publicació de la revista: 2008
    Pàgina inicial: 2449
    Tipus de publicació: Article Artículo Article

  • Paraules clau:

    Fruita seca
    Dieta mediterrània
    Síndrome metabòlica
    Metabolic Syndrome Status
    PREDIMED study
    Randomized trial
    Biochemistry and technology
    Bioquímica y tecnología
    Bioquímica i biotecnologia
    0003-9926

  • Documents:

    DocumentPrincipal

  • Cerca a google

    Search to google scholar